Relationship between glycemic control and histochemical myeloperoxidase activity in neutrophils in patients with type 2 diabetes
Open Access
- 30 December 2015
- journal article
- research article
- Published by Springer Nature in Diabetology & Metabolic Syndrome
- Vol. 7 (1) , 1-7
Abstract
Myeloperoxidase (MPO) is a lysosomal hemoprotein found in the azurophilic granules in neutrophils. Myeloperoxidase plays an important role in oxygen-dependent killing of bacteria, fungi, virus and malignant cells. Diabetes mellitus (DM) is listed among conditions that may lead to secondary MPO deficiency in neutrophils but inconsistent results concerning MPO activity in diabetic patients have been reported in the literature. In this study, we aimed to evaluate the relationship between glycemic control in patients with type 2 DM and MPO activity in neutrophils from a histochemical perspective. The study included 40 patients with type 2 DM with poor glycemic control, 30 patients with type 2 DM with good glycemic control and 31 healthy controls. Peripheral blood smears were analyzed for each patient included in the study. Myeloperoxidase dye was used for staining. Myeloperoxidase ratios in neutrophil were evaluated for proportions of staining with MPO in 100 neutrophils in each smear. SPSS 16.0 version was used for statistical analyses. Myeloperoxidase ratios in neutrophils were 70 (58.5–80) in type 2 DM patients with poor glycemic control compared to 80 (73.75–90) in those with good glycemic control and 88 (78–92) in healthy controls. The DM group with poor glycemic control was statistically significantly different from the other groups (p < 0.001). Poor glycemic control in diabetic patients results in decreased MPO activity in neutrophils histochemically.Keywords
This publication has 35 references indexed in Scilit:
- Plasma Myeloperoxidase Predicts Incident Cardiovascular Risks in Stable Patients Undergoing Medical Management for Coronary Artery DiseaseClinical Chemistry, 2011
- Diabetes-Induced Oxidative Stress Is Mediated by Ca2+-Independent Phospholipase A2 in NeutrophilsThe Journal of Immunology, 2010
- Neutrophils and monocytes as potentially important sources of proinflammatory cytokines in diabetesClinical and Experimental Immunology, 2006
- Plasma markers of endothelial dysfunction in type 2 diabeticsEuropean Journal of Internal Medicine, 2006
- Genetic characterization of myeloperoxidase deficiency in ItalyHuman Mutation, 2004
- Amlodipine reverses the elevation in [Ca2+]i and the impairment of phagocytosis in PMNLs of NIDDM patientsKidney International, 2003
- Biochemistry and molecular cell biology of diabetic complicationsNature, 2001
- Consequences of Total and Subtotal Myeloperoxidase Deficiency: Risk or Benefit ?Acta Haematologica, 2000
- Antioxidant systems in polymorphonuclear leucocytes of Type 2 diabetes mellitusDiabetic Medicine, 1999
- Neutrophil Bactericidal Function in Diabetes Mellitus: Evidence for Association with Blood Glucose ControlDiabetic Medicine, 1995